drugset / Trial / NCT00784875
An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to compare an investigational drug (LY2624803) with placebo and with zolpidem in the treatment of outpatients with chronic insomnia.
Timeline
- Start
- 2008-10
- Primary completion
- 2010-02
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2624803 | Small molecule | 1 mg | Oral |
| Subject | LY2624803 | Small molecule | 3 mg | Oral |
| Subject | Zolpidem | Small molecule | 5 mg | Oral |
| Subject | Zolpidem | Small molecule | 10 mg | Oral |